cancer,gender,trial_participants,proportion_of_incident_cases,proportion_of_us_population
"Lung, CRC, Prostatic, Breast, Ovarian combined",Male,49.852838751713136,53.817727079371124,49.14681196453067
"Lung, CRC, Prostatic, Breast, Ovarian combined",Female,50.147161248286864,46.18227292062887,50.85318803546932
Lung,Male,59.40630837154016,58.406478073089765,49.14681196453067
Lung,Female,40.59369162845984,41.593521926910235,50.85318803546932
CRC,Male,53.27768037055453,55.86124695320165,49.14681196453067
CRC,Female,46.72231962944547,44.13875304679834,50.85318803546932
